Financial Daily from THE HINDU group of publications
Tuesday, Nov 16, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Announcements


SBL conducting trials for homeopathic drugs

P.T. Jyothi Datta

Mumbai , Nov. 15

IT may seem odd to associate homeopathic companies with clinical trials. But Uttar Pradesh-based SBL is working on a clutch of innovative homeopathic medicines and even doing clinical trials for a couple of them at New Delhi's Escorts Hospital.

SBL expects to come out with two innovative drugs — made of neem leaves and a dust allergen, respectively — in a year, said Dr Beena Thomas, Head of R&D at SBL.

Meanwhile, the company is doing trials for its heart-related medicine Tonicard and Tranquil (used for anxiety and depression) at the Escorts Hospital, she said.

"We are looking at whether Tonicard can be used as an adjunct or add-on during therapy using allopathic drugs. The medicine is already in the market. We are undertaking further trials to see how it works for cardiac patients on allopathic drugs. Similarly, Tranquil is also undergoing trials in Escorts." Elaborating on the work done on neem leaves, she said that the extract is being "clinically verified" for skin, joint and muscular applications. SBL expects to introduce the medicine in "Materia Medica", the virtual "Bible for homeopaths", in a year, she said.

In this time, the company also expects to submit its documents to the Drug Controller General of India for approval. Dr Thomas expected to be able to market both drugs in about a year.

On similar lines, SBL is also working on a house-dust allergen and is testing it for skin conditions associated with respiratory problems. The medicine is being clinically tried with ENT specialists, she said.

Meanwhile, she said, SBL was also working on other innovative therapies that combined homeopathic medicines.

The Rs 35-crore SBL has production units at Jaipur and Majitar (Sikkim) and its R&D spend is about 6-10 per cent of the profits, top officials with SBL said.

More Stories on : Announcements | Alternative Medicines

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Media Video gets Rs 10-cr order from Haier Group


SBL conducting trials for homeopathic drugs
AHLCON bags Rs 6.5-cr order
ICSI for making secretarial standards must for listed cos
ITC Centre bags Platinum Green Building rating from US agency
Ranbaxy, other drug cos face £94.5 m claim in UK
Converting Rs 52-cr dues into equity — CIAL, Hudco face-off drags on
Temasek arm picks up 6.9 pc stake in Satnam Overseas
Korean major to set up chip facility in Hyderabad
The Park plans one more hotel in Bangalore
Escorts Auto scouting for foreign partner
CUMI eyes China, Dubai for growth
Rise in number of cos registered in Sept



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line